Screener
Aurinia Pharmaceuticals AUPH Total cash, cash equivalents, restricted cash and short-term investments
Total cash, cash equivalents, restricted cash and short-term investments at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept auph:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAndShortTermInvestments.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | Amortized Cost | Unrealized Gains | Unrealized Losses | Estimated Fair Value |
|---|---|---|---|---|
| U.S. treasury bills | 190,316 | — | (235) | 190,081 |
| U.S. treasury bonds | 69,402 | — | (57) | 69,345 |
| Commercial paper | 3,865 | — | — | 3,865 |
| Total cash, cash equivalents, restricted cash and short-term investments | $443,415 | — | $(292) | $443,123 |
| December 31, 2025 | ||||
| Amortized Cost | Unrealized Gains | Unrealized Losses | Estimated Fair Value | |
| Cash, cash equivalents and restricted cash | $80,213 | — | — | $80,213 |
| U.S. treasury bills | 254,875 | 159 | — | 255,034 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's total cash, cash equivalents, restricted cash and short-term investments?
- Aurinia Pharmaceuticals (AUPH) reported total cash, cash equivalents, restricted cash and short-term investments of $443.12M in Q2 2026.
- How has Aurinia Pharmaceuticals's total cash, cash equivalents, restricted cash and short-term investments changed year-over-year?
- Aurinia Pharmaceuticals's total cash, cash equivalents, restricted cash and short-term investments increased by 40.6% year-over-year, from $315.13M to $443.12M.
- What is the long-term trend for Aurinia Pharmaceuticals's total cash, cash equivalents, restricted cash and short-term investments?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's total cash, cash equivalents, restricted cash and short-term investments has grown at a -3.9% compound annual growth rate (CAGR), from $466.08M to $398M.
- What does total cash, cash equivalents, restricted cash and short-term investments mean?
- Total cash, cash equivalents, restricted cash and short-term investments as reported by Aurinia Pharmaceuticals Inc.
Ask your AI about Aurinia Pharmaceuticals's total cash, cash equivalents, restricted cash and short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude